Spike gene evolution and immune escape mutations in patients with mild or moderate forms of covid-19 and treated with monoclonal antibodies therapies

HIGHLIGHTS

• who: Aude Jary and collaborators from the Institut Pierre Louis d'Epidémiologie de Santé (iPLESP), Paris, France have published the research work: Spike Gene Evolution and Immune Escape Mutations in Patients with Mild or Moderate Forms of COVID-19 and Treated with Monoclonal Antibodies Therapies, in the Journal: Viruses 2022, 14, 226. of 21/01/2022
• what: The authors aimed to describe the evolution of the spike gene sequence in patients treated with mAbs therapy to prevent progression to a severe form of COVID-19.
• how: The study was carried out in . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.